105 related articles for article (PubMed ID: 24506577)
1. Rapid Resolution of Graft-versus-Host-Disease-Related Central Serous Chorioretinopathy.
Ng SK; Durkin S; Gilhotra JS
Semin Ophthalmol; 2015; 30(5-6):432-4. PubMed ID: 24506577
[TBL] [Abstract][Full Text] [Related]
2. Graft-vs-host-disease-associated conjunctival chemosis and central serous chorioretinopathy after bone marrow transplant.
Cheng LL; Kwok AK; Wat NM; Neoh EL; Jon HC; Lam DS
Am J Ophthalmol; 2002 Aug; 134(2):293-5. PubMed ID: 12140049
[TBL] [Abstract][Full Text] [Related]
3. [Chorioretinopathy as the first symptom of acute lymphoblastic leukaemia].
Grønbech KT; Rewes A; Grauslund J
Ugeskr Laeger; 2014 Jan; 176(3A):V07130455. PubMed ID: 25347176
[TBL] [Abstract][Full Text] [Related]
4. GRAFT-VERSUS-HOST DISEASE PANUVEITIS AND BILATERAL SEROUS DETACHMENTS: MULTIMODAL IMAGING ANALYSIS.
Jung JJ; Chen MH; Rofagha S; Lee SS
Retin Cases Brief Rep; 2017 Winter; 11 Suppl 1():S54-S61. PubMed ID: 27571426
[TBL] [Abstract][Full Text] [Related]
5. Clinical parameters related to metamorphopsia outcome in patients with resolved central serous chorioretinopathy using M-CHARTS: retrospective cohort study.
Bae S; Jin K; Kim H; Bae SH
BMC Ophthalmol; 2015 Dec; 15():180. PubMed ID: 26677843
[TBL] [Abstract][Full Text] [Related]
6. Atypical acute graft-versus-host disease.
Shin J; Hong W; Song H; Choi G; Kim YC
Am J Dermatopathol; 2007 Dec; 29(6):576-7. PubMed ID: 18032957
[TBL] [Abstract][Full Text] [Related]
7. Central serous chorioretinopathy after bone marrow transplantation.
Fawzi AA; Cunningham ET
Am J Ophthalmol; 2001 Jun; 131(6):804-5. PubMed ID: 11384585
[TBL] [Abstract][Full Text] [Related]
8. Value of three-dimensional optical coherence tomography and fundus photochromy in correlating the fluorescein leaking sites of acute central serous chorioretinopathy.
Wang GH; Zhang J; Zhang D; Lv FL; Wang LX
Med Princ Pract; 2011; 20(3):283-6. PubMed ID: 21455001
[TBL] [Abstract][Full Text] [Related]
9. Nephrotic syndrome as a clinical manifestation of graft-versus-host disease (GVHD) in a marrow transplant recipient after cyclosporine withdrawal.
Oliveira JS; Bahia D; Franco M; Balda C; Stella S; Kerbauy J
Bone Marrow Transplant; 1999 Jan; 23(1):99-101. PubMed ID: 10037059
[TBL] [Abstract][Full Text] [Related]
10. Central serous chorioretinopathy in patients receiving exogenous testosterone therapy.
Nudleman E; Witmer MT; Kiss S; Williams GA; Wolfe JD
Retina; 2014 Oct; 34(10):2128-32. PubMed ID: 24946102
[TBL] [Abstract][Full Text] [Related]
11. Central serous chorioretinopathy following kidney transplantation.
Farzan K; Rezaei L; Ghanbari H; Dehghani A
Saudi J Kidney Dis Transpl; 2014 May; 25(3):615-20. PubMed ID: 24821161
[TBL] [Abstract][Full Text] [Related]
12. Bilateral central serous retinopathy following laser in situ keratomileusis for myopia.
Peponis VG; Chalkiadakis SE; Nikas SD; Makris NK; Ladas ID; Karagiannis DA
J Cataract Refract Surg; 2011 Apr; 37(4):778-80. PubMed ID: 21420605
[TBL] [Abstract][Full Text] [Related]
13. True, true and related?
Ebner R; DaCol E; Bullorsky E
Surv Ophthalmol; 2001; 45(6):489-92. PubMed ID: 11425355
[TBL] [Abstract][Full Text] [Related]
14. Impact of cyclosporine and methylprednisolone dose used for prophylaxis and therapy of graft-versus-host disease on survival and relapse after allogeneic bone marrow transplantation.
Michallet M; Perrin MC; Belhabri A; Molina L; Nicolini F; Tigaud JD; Sotto JJ; Guyotat D; Fière D; Archimbaud E
Bone Marrow Transplant; 1999 Jan; 23(2):145-50. PubMed ID: 10197799
[TBL] [Abstract][Full Text] [Related]
15. Traumatic central serous chorioretinopathy.
Steeples L; Sharma V; Mercieca K
Indian J Ophthalmol; 2015 Jun; 63(6):536-8. PubMed ID: 26265647
[TBL] [Abstract][Full Text] [Related]
16. Fecal microbiota transplantation with frozen capsules for a patient with refractory acute gut graft-versus-host disease.
Kaito S; Toya T; Yoshifuji K; Kurosawa S; Inamoto K; Takeshita K; Suda W; Kakihana K; Honda K; Hattori M; Ohashi K
Blood Adv; 2018 Nov; 2(22):3097-3101. PubMed ID: 30446486
[TBL] [Abstract][Full Text] [Related]
17. Cyclosporine-A as GVHD prophylaxis in allogeneic BMT for childhood acute leukemia. AIEOP-BMT group.
Pession A; Locatelli F; Zecca M; Rondelli R; Prete A; Bonetti F; Paolucci G
Bone Marrow Transplant; 1998 Apr; 21 Suppl 2():S50-2. PubMed ID: 9630326
[TBL] [Abstract][Full Text] [Related]
18. Pseudotumor cerebri after allogeneic bone marrow transplant associated with cyclosporine a use for graft-versus-host disease prophylaxis.
Somech R; Doyle J
J Pediatr Hematol Oncol; 2007 Jan; 29(1):66-8. PubMed ID: 17230071
[TBL] [Abstract][Full Text] [Related]
19. A prospective pilot study of intravitreal aflibercept for the treatment of chronic central serous chorioretinopathy: the CONTAIN study.
Pitcher JD; Witkin AJ; DeCroos FC; Ho AC
Br J Ophthalmol; 2015 Jun; 99(6):848-52. PubMed ID: 25595177
[TBL] [Abstract][Full Text] [Related]
20. A novel treatment of central serous chorioretinopathy with topical anti-inflammatory therapy.
Chong CF; Yang D; Pham TQ; Liu H
BMJ Case Rep; 2012 Sep; 2012():. PubMed ID: 22949003
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
